Drugs / Dimethyltryptamin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05829603 | May → Sep 2023 | — | Reconnect Labs | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dimethyltryptamin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05829603 ↗ |
| Known as | DMT | “Dimethyltryptamin (DMT) & Harmine” NCT05829603 ↗ |